Parenteral Drugs Market

Global Parenteral Drugs Market: Overview

Parenteral drugs are pharmaceutical preparations given by any other route besides by mouth or anally. Any enteral preparation has to pass through the stomach and liver before being absorbed into the body and a sizeable part is destroyed or modified by these organs. Hence, parenteral preparations are made for drugs that should reach target organs in almost unchanged form. Also, the time to achieve therapeutic blood level reduces with these preparations. 

These drugs are currently in increased demand given the rise of all types of diseases worldwide, especially chronic ones that require long term therapy. Since parenteral entry often requires basic paramedic training, these drugs are seldom self-administered and therefore majorly found in professional healthcare settings. The rise in demand for good healthcare is anticipated to bring a concomitant rise to the parenteral drug market. 

From 2020 to 2030, Transparency Market Research notes, global parenteral drugs market would grow at a decent CAGR, driving the market on to a notable growth curve, adding o the market worth by a significant value.

Global Parenteral Drugs Market: Competitive Landscape

The global parenteral drugs market is dotted by a number of manufactures, which makes the market’s vendor landscape fragmented. Some of these distinguished manufactures in the global parenteral drugs market are listed below.

• Beximco Pharma
• Baxter Healthcare Corporation
• Cook Pharmica
• Teva Pharmaceutical Industries
• Ostuka Pharmaceutical
• Kelun Pharma
• Fresenius
• BAG Healthcare
• Patheon
• B. Braun
• Ozon Pharmaceuticals Ltd
• Wintac Limited
• Albert David
• Acebright
• Aspen Holdings
• Pisa
• BML Parenteral Drugs
• AXA Parenterals Ltd
• PSI Ltd
• Pfizer (Hospira)
• Southwest Pharmaceutical
• Abbott

These manufactures are already established in the pharmaceutical industry and are currently looking to expand production and improve market penetration in untapped region by entering alliances based on mutual synergies, product development, etc. 

Global Parenteral Drugs Market: Key Trends and Drivers

• Parenteral drugs are crucial for chronic diseases like cancer, diabetes, coronary heart disease among others because it is necessary that drugs reach target organs quickly and in the original form. According to the World Health Organization, the prevalence of chronic diseases is rising worldwide and is estimated to be about 57% by the year 2020. This is set to impact growth in global pareneteral drugs market in a positive manner. Additionally, it is worth noting here that these drugs are used in healthcare settings due to expertise required to administer them. With global healthcare spending expected to rise by 5% over the next 3 years, the parenteral drugs market is set to get a boost.
• A hindrance to the growth of these drugs could be the aversion people have to any drug formulation which is not given orally. Since expertise is required for parenteral entry, these drugs cannot be taken by individuals themselves. Being painful they are often avoided. This factor can be counteracted by Needle Free Injection Technologies, which make use of natural physical forces to drive drugs into the patient's skin, often being minimally painful.

Global Parenteral Drugs Market: Regional Analysis

North America and Europe currently garner the maximum share of this market. This growth can be pinned on to an existing healthcare setup that is robust and on to an aware population that understands the importance of healthcare.

The Asia Pacific region (APAC) is expected to grow at the fastest rate over the forecast period owing to growing healthcare penetration into this region and a high level of trust for allopathic preparations in this inherently diverse healthcare market.